ARMAUER HANSEN RESEARCH INSTITUTE

Forschungsprojekte

• SEROLOGICAL TESTING AND TREATMENT FOR P. VIVAX: FROM A CLUSTER-RANDOMISED TRIAL IN ETHIOPIA AND MADAGASCAR TO A MOBILE-TECHNOLOGY SUPPORTED INTERVENTION P. vivax is considered the most difficult human malaria to eliminate because of the inability of conventional…
• A holistic approach in patient management and epidemic surveillance through convergence of diagnostic technologies, capacity building and stakeholder engagement Research on Poverty-Related Diseases (PRDs) in sub-Saharan Africa suffers from major technological and non-te…
• Optimising a High Efficacy Plasmodium vivax Malaria Vaccine Plasmodium vivax is the most widespread human malaria with 2.5 billion people living at risk in South America…
• BUILDING SCALABLE PATHOGEN GENOMIC EPIDEMIOLOGY FOR ETHIOPIA The 21st century witnesses increased incidence of epidemics (Zika, dengue, Ebola, SARS), with as latest highl…